TLX

Telix Pharmaceuticals Limited is a dynamic commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, specializing in the development of radiopharmaceuticals for the diagnosis and treatment of cancer and rare diseases. Operating in key international markets such as the United States, Belgium, Japan, and Switzerland, the company harnesses its innovative expertise to address significant unmet medical needs. Committed to enhancing patient outcomes through its targeted therapeutic and diagnostic solutions, Telix is well-positioned to make a substantial impact in the rapidly evolving biopharmaceutical sector.